ISRCTN10862406已完成不适用
Fibrin sealant to reduce blood loss after hip replacement
Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)0 个研究点目标入组 90 人开始时间: 2003年9月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Primary hip replacement: 60 patients not on anticoagulant medications, without blood autoantibodies and with pre-operation Hb level >12.5 will be randomised into treatment and control groups.
- •Revision Hip Replacement: 30 consecutive patients in treatment group not randomized. Control group will be historical, with information regarding blood loss gained from a retrospective review of notes.
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Efficacy of fibrin sealant in reducing resection surface crelated complications after partial liver resectionsISRCTN85205641Johnson and Johnson Medical Limited (UK)600
已完成
4 期
Post-Operative Drainage Following Lymph Node DissectionMalignant MelanomaCarcinoma, Squamous CellNCT00324272Oxford University Hospitals NHS Trust74
已完成
2 期
Use of a Novel Fibrin Sealant in Total Knee ArthroplastyIntraoperative BleedingOsteoarthritisNCT01656759Rush University Medical Center73
已完成
3 期
Efficacy of Fibrin Sealant to Reduce the Amount of Post-thyroidectomy DrainThyroidectomyThyroid CarcinomaNCT01126060Samsung Medical Center78
已完成
不适用
The Use of Fibrin Sealant to Reduce Bleeding After Total Knee ReplacementTotal Knee ReplacementPrimary Knee ArthroplastyOsteoarthritis of the KneeNCT01816282University of Milan62